门静脉系统血栓的介入治疗

马婧嶔; 罗剑钧

doi:10.3969/j.issn.1001-5256.2018.10.003

门静脉系统血栓的介入治疗

DOI: 10.3969/j.issn.1001-5256.2018.10.003

复旦大学附属中山医院介入科

基金项目:

上海市卫生和计划生育委员会(201540272);上海市卫生和计划生育委员会(20174Y0057)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3211
- HTML全文浏览量: 18
- PDF下载量: 409
- 被引次数: 0
出版历程
- 出版日期: 2018-10-20

Interventional treatment of portal vein thrombosis

Department of Interventional Radiology, Zhongshan Hospital, Fudan University

Research funding:

摘要

摘要: 随着门静脉系统血栓(PVT)的确诊率不断提高,针对PVT的介入治疗也日益受到重视。机械性碎栓及药物性溶栓配合全身性抗凝治疗能部分甚至完全地逆转门静脉血栓后的局部及全身性血流动力学改变,恢复门静脉血流,降低门静脉压力。介入治疗PVT需根据不同情况选择合适的治疗方法及途径。经肠系膜上动脉途径创伤及风险相对较小,但对亚急性、慢性血栓或侧支已形成的单纯门静脉主干血栓溶栓效果多不理想。经门静脉途径是目前最常用的介入治疗手段,包括经皮穿肝、经皮穿脾和经肠系膜静脉等多种入路。经颈静脉肝内门体分流术治疗可为门静脉系统提供一个低阻力的流出道,降低门静脉压力、改善门静脉血流瘀滞。PVT的介入治疗是多手段多途径联合的综合介入治疗。根据病情分别或联合应用多种治疗途径及多种治疗手段能取得更好疗效并降低并发症和病死率。
- 静脉血栓形成 /
- 门静脉 /
- 外科手术,微创性
Abstract: With the increase in the diagnosis rate of portal vein thrombosis ( PVT) , the interventional treatment for PVT has attracted more and more attention. Mechanical thrombolysis and drug thrombolysis combined with systemic anticoagulant treatment can partly or even completely reverse the local and systemic hemodynamic changes after PVT, restore portal venous flow, and reduce portal venous pressure. The methods and approaches for interventional treatment should be selected based on patients' conditions. The superior mesenteric artery approach has a relatively low risk, but it does not have a satisfactory thrombolytic effect in subacute/chronic PVT or PVT in the main portal vein with collateral formation. The portal vein approach is the most commonly used method for interventional treatment at present, including the percutaneous transhepatic approach, the percutaneous trans-splenic approach, and the mesenteric vein approach. Transjugular intrahepatic portosystemic shunt can provide a low-resistance outlet for the portal system and thus reduce portal venous pressure and improve blood stream stasis in the portal vein. The interventional treatment of PVT is a comprehensive interventional therapy that combines multiple methods and approaches. These methods and approaches used alone or in combination based on patients' conditions can achieve a good clinical effect and reduce complications and mortality.
- venous thrombosis /
- portal vein /
- surgical procedures, minimally invasive

HTML全文

参考文献(49)

[1]CONDAT B, PESSIONE F, HELENE DENNINGER M, et al.Recent portal or mesenteric venous thrombosis:Increased recognition and frequent recanalization on anticoagulant therapy[J].Hepatology, 2000, 32 (3) :466-470.

[2] HANDA P, CROWTHER M, DOUKETIS JD.Portal vein thrombosis:A clinician-oriented and practical review[J].Clin Appl Thromb Hemost, 2014, 20 (5) :498-506.

[3]BELLI L, ROMANI F, SANSALONE CV, et al.Portal thrombosis in cirrhotics.A retrospective analysis[J].Ann Surg, 1986, 203 (3) :286-291.

[4]NONAMI T, YOKOYAMA I, IWATSUKI S, et al.The incidence of portal vein thrombosis at liver transplantation[J].Hepatology, 1992, 16 (5) :1195-1198.

[5]MANTAKA A, AUGOUSTAKI A, KOUROUMALIS EA, et al.Portal vein thrombosis in cirrhosis:Diagnosis, natural history, and therapeutic challenges[J].Ann Gastroenterol, 2018, 31 (3) :315-329.

[6]DELL'ERA A, IANNUZZI F, FABRIS FM, et al.Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation[J].Dig Liver Dis, 2014, 46 (2) :152-156.

[7]AMITRANO L, GUARDASCIONE MA, SCAGLIONE M, et al.Prognostic factors in noncirrhotic patients with splanchnic vein thromboses[J].Am J Gastroenterol, 2007, 102 (11) :2464-2470.

[8]TURNES J, GARCIA-PAGAN JC, GONZALEZ M, et al.Portal hypertension-related complications after acute portal vein thrombosis:impact of early anticoagulation[J].Clin Gastroenterol Hepatol, 2008, 6 (12) :1412-1417.

[9]de FRANCHIS R.Evolving consensus in portal hypertension.Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol, 2005, 43 (1) :167-176.

[10]SENZOLO M, M SARTORI T, ROSSETTO V, et al.Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis[J].Liver Int, 2012, 32 (6) :919-927.

[11]KUMAR S, SARR MG, KAMATH PS.Mesenteric venous thrombosis[J].N Engl J Med, 2001, 345 (23) :1683-1688.

[12] PLESSIER A, DARWISH-MURAD S, HERNANDEZ-GUERRA M, et al.Acute portal vein thrombosis unrelated to cirrhosis:A prospective multicenter follow-up study[J].Hepatology, 2010, 51 (1) :210-218.

[13] HALL TC, GARCEA G, METCALFE M, et al.Management of acute non-cirrhotic and non-malignant portal vein thrombosis:A systematic review[J].World J Surg, 2011, 35 (11) :2510-2520.

[14]HOEKSTRA J, JANSSEN HL.Vascular liver disorders (II) :Portal vein thrombosis[J].Neth J Med, 2009, 67 (2) :46-53.

[15]CONDAT B, PESSIONE F, HILLAIRE S, et al.Current outcome of portal vein thrombosis in adults:Risk and benefit of anticoagulant therapy[J].Gastroenterology, 2001, 120 (2) :490-497.

[16]SOGAARD KK, ASTRUP LB, VILSTRUP H, et al.Portal vein thrombosis;Risk factors, clinical presentation and treatment[J].BMC Gastroenterol, 2007, 7:34.

[17]HOLLINGSHEAD M, BURKE CT, MAURO MA, et al.Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis[J].J Vasc Interv Radiol, 2005, 16 (5) :651-661.

[18]WANG W, SHI J, XIE WF.Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma:A meta-analysis[J].Liver Int, 2010, 30 (5) :741-749.

[19]BELNAP L, ZAVERI H, COTTAM D, et al.What is the optimal treatment of superior mesenteric vein/portal vein thrombosis after bariatric surgery?Is SMA-directed t-PA the answer?[J].Surg Obes Relat Dis, 2017, 13 (3) :533-537.

[20]LIU K, LI WD, DU XL, et al.Comparison of systemic thrombolysis versus indirect thrombolysis via the superior mesenteric artery in patients with acute portal vein thrombosis[J].Ann Vasc Surg, 2017, 39:264-269.

[21]LUO X, YANG L.Could TIPS be applied in all kinds of portal vein thrombosis:We are not sure![J].Ann Hepatol, 2017, 16 (6) :979.

[22]ZHOU W, CHOI L, LIN PH, et al.Percutaneous transhepatic thrombectomy and pharmacologic thrombolysis of mesenteric venous thrombosis[J].Vascular, 2007, 15 (1) :41-45.

[23]OZKAN U, OGUZKURT L, TERCAN F, et al.Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis[J].Diagn Interv Radiol, 2006, 12 (2) :105-107.

[24]ADANI GL, BACCARANI U, RISALITI A, et al.Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery[J].Cardiovasc Intervent Radiol, 2007, 30 (6) :1222-1226.

[25]LOPERA JE, CORREA G, BRAZZINI A, et al.Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis[J].J Vasc Surg, 2002, 36 (5) :1058-1061.

[26]KIM HS, PATRA A, KHAN J, et al.Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis[J].J Vasc Interv Radiol, 2005, 16 (12) :1685-1691.

[27]GUERRERO-HERNANDEZ M, HINOJOSA CA, ANAYA-AY-ALA JE, et al.Endovascular reconstruction of extrahepatic portal vein in noncirrhotic and nonmalignant chronic portal vein thrombosis secondary to an iatrogenic stenotic lesion[J].Vasc Endovascular Surg, 2016, 50 (8) :559-562.

[28]TUITE DJ, REHMAN J, DAVIES MH, et al.Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis[J].J Vasc Interv Radiol, 2007, 18 (12) :1571-1575.

[29]OHM JY, KO GY, SUNG KB, et al.Safety and efficacy of transhepatic and transsplenic access for endovascular management of portal vein complications after liver transplantation[J].Liver Transpl, 2017, 23 (9) :1133-1142.

[30]DOLLINGER M, GOESSMANN H, MUELLER-WILLE R, et al.Percutaneous transhepatic and transsplenic portal vein access:Embolization of the puncture tract using amplatzer vascular plugs[J].Rofo, 2014, 186 (2) :142-150.

[31]KAPLAN JL, WEINTRAUB SL, HUNT JP, et al.Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter[J].Am Surg, 2004, 70 (7) :600-604.

[32]BOYER TD, HASKAL ZJ.The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension[J].Hepatology, 2005, 41 (2) :386-400.

[33]BILBAO JI, QUIROGA J, HERRERO JI, et al.Transjugular intrahepatic portosystemic shunt (TIPS) :Current status and future possibilities[J].Cardiovasc Intervent Radiol, 2002, 25 (4) :251-269.

[34]PERARNAU JM, BAJU A, D'ALTEROCHE L, et al.Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis[J].Eur J Gastroenterol Hepatol, 2010, 22 (9) :1093-1098.

[35]LUO J, YAN Z, WANG J, et al.Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach[J].J Vasc Interv Radiol, 2011, 22 (1) :61-69.

[36]BLUM U, HAAG K, ROSSLE M, et al.Noncavernomatous portal vein thrombosis in hepatic cirrhosis:Treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis[J].Radiology, 1995, 195 (1) :153-157.

[37]DUMORTIER J, WALTER T, GUILLAUD O, et al.Transcatheter local thrombolysis in patients with extensive TIPS thrombosis[J].Gastroenterol Clin Biol, 2010, 34 (12) :721-725.

[38]UFLACKER R.Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis[J].Tech Vasc Interv Radiol, 2003, 6 (1) :59-69.

[39]ANGERMAYR B, CEJNA M, KOENIG F, et al.Survival in patients undergoing transjugular intrahepatic portosystemic shunt:e PT-FE-covered stentgrafts versus bare stents[J].Hepatology, 2003, 38 (4) :1043-1050.

[40]BUREAU C, GARCIA PAGAN JC, LAYRARGUES GP, et al.Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:Long-term results of a randomized multicentre study[J].Liver Int, 2007, 27 (6) :742-747.

[41] HAN GH, MENG XJ, YIN ZX, et al.Transjugular intrahepatic portosystemie shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation[J].Natl Med J China, 2009, 89 (22) :1549-1552. (in Chinese) 韩国宏, 孟祥杰, 殷占新, 等.经颈内静脉肝内门腔分流术及联合经皮肝/脾穿刺途径治疗门静脉血栓和 (或) 海绵样变性[J].中华医学杂志, 2009, 89 (22) :1549-1552.

[42]SENZOLO M, CHOLONGITAS E, TIBBALLS J, et al.Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome[J].Eur J Gastroenterol Hepatol, 2006, 18 (11) :1143-1150.

[43]LUCA A, MIRAGLIA R, CARUSO S, et al.Short-and longterm effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis[J].Gut, 2011, 60 (6) :846-852.

[44]WILS A, van der LINDEN E, van HOEK B, et al.Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation[J].J Clin Gastroenterol, 2009, 43 (10) :982-984.

[45]CHEN L, XIAO T, CHEN W, et al.Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs.the right branch of the portal vein in advanced cirrhosis:A randomized trial[J].Liver Int, 2009, 29 (7) :1101-1109.

[46]HAN G, QI X, HE C, et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis[J].J Hepatol, 2011, 54 (1) :78-88.

[47]QI X, HAN G, YIN Z, et al.Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients[J].Dig Dis Sci, 2012, 57 (4) :1072-1082.

[48]LOFFREDO L, PASTORI D, FARCOMENI A, et al.Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis:Asystematic review and meta-analysis[J].Gastroenterology, 2017, 153 (2) :480-487, e1.

[49]SALSAMENDI JT, GORTES FJ, SHNAYDER M, et al.Transsplenic portal vein reconstruction-transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis[J].Radiol Case Rep, 2016, 11 (3) :186-189.

施引文献

资源附件(0)

访问统计